Although not as strong as agonist peptide induced shCtrl cells, mock treated shCtrl cells also present higher migration rates than shPAR1 cells both with or without PAR1-AP stimulation, meaning that endogenous PAR1 activity already operates the migratory activity of pancreatic cancer cells. This evidence concerns the gene F2R and familial pancreatic carcinoma.